<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10127">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02156505</url>
  </required_header>
  <id_info>
    <org_study_id>NCCCTSMD12009</org_study_id>
    <nct_id>NCT02156505</nct_id>
  </id_info>
  <brief_title>Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction</brief_title>
  <official_title>Phase IV Study of Double Bare Self-expandable Metallic Stent for Malignant Gastric Outlet Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stent research group, Korean Society of Gastrointestinal Endoscopy, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <authority>Republic of Korea: Ministry of food and drug safety</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Self-expandable metallic stents provide effective palliation of malignant gastric outlet
      obstruction. However, uncovered stent are often associated with re-stenosis caused by tumor
      in-growth through the stent mesh. The Self-expandable metallic stents which has the design
      of smaller wire mesh size (double bare stent) were developed and used in Korea. This new
      design was developed to minimize the re-stenosis of uncovered stent, but the outcome is
      unknown. The end point of this study is the 8-weeks patency rate after placement of double
      bare as well as technical and clinical success rates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The patency rate at 8 weeks after placement.</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical and clinical success rates</measure>
    <time_frame>up to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-stenosis rate</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>migration rate</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">49</enrollment>
  <condition>Gastric Outlet Obstruction Due to Malignancy</condition>
  <arm_group>
    <arm_group_label>DoubleBare stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of double bare stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placement of double bare stent</intervention_name>
    <arm_group_label>DoubleBare stent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DoubleBare stent</intervention_name>
    <arm_group_label>DoubleBare stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Malignant gastric outlet obstruction

          -  Symptoms compatible with gastric outlet obstruction

          -  An inoperable condition because of extent of disease or patient's conditions

        Exclusion Criteria:

          -  History of enteral stent placement, undergone gastric surgery.

          -  Additional small bowel stenosis distal to gastric outlet obstruction.

          -  Refuse to be enrolled to study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chan G Kim, M.D.</last_name>
    <phone>+82-31-920-1620</phone>
    <email>glse@chol.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan G Kim, M.D.</last_name>
      <phone>+82-31-920-1620</phone>
      <email>glse@chol.com</email>
    </contact>
    <investigator>
      <last_name>Chan G Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 4, 2014</lastchanged_date>
  <firstreceived_date>June 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Chan Gyoo Kim</investigator_full_name>
    <investigator_title>Senior scientist</investigator_title>
  </responsible_party>
  <keyword>stent</keyword>
  <keyword>gastric outlet obstruction</keyword>
  <keyword>restenosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Gastric Outlet Obstruction</mesh_term>
    <mesh_term>Pyloric Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
